300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Cannabis
Beauty
Infrastructure
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
LGBT
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Celebrity
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Climate
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Brazil
Tajikistan
Mexico
Nigeria
Russian Federation
Kyrgyzstan
Togo
LATAM
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Africa
Oceania
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Namibia
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Morocco
Venezuela
Malawi
Myanmar
Uganda
Turkey
Moldova
Uruguay
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Canada
Georgia
Denmark
Ghana
United Kingdom
Iraq
Mali
Malaysia
Latvia
Portugal
Philippines
Sierra Leone
El Salvador
Rwanda
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Angola
Europe
Cyprus
Bangladesh
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Liechtenstein
Cambodia
Honduras
Lithuania
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 40 Biotech Angel Investors in LATAM (August 2026)

The most active angel investors investing in LATAM Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in LATAM Biotech startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Kevin Efrusy
Angel
2 Brazil, United States, Mexico Series B, Series A, Series C Software, E-Commerce, FinTech $6M–$100M
Pablo Pla
Angel
1 Argentina Seed Biopharma, Biotechnology, Food Processing
Franco Goytia
Angel
1 Argentina Seed Health Care, Biotechnology, Health Diagnostics
Ignacio Smith
Angel
1 Chile Seed Farming, Chemical, Agriculture
Daniel Gold
Angel
1 Brazil Pre-Seed Genetics, Life Science, Biotechnology
Nadav Ben-Chanoch
Angel
1 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, Information Technology, Artificial Intelligence $120k–$30M
Edward Lando
Angel
1 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, Artificial Intelligence, FinTech $125k–$37M
Robert Stavis
Angel
1 United States, Canada, United Kingdom Series C, Series B, Series A Financial Services, FinTech, Finance $3.9M–$126M
Peter Andersen
Angel
1 Brazil Series A Chemical, Biopharma, Biotechnology
Thomas James
Angel
1 Mexico Seed Health Care, Biotechnology, Health Diagnostics $52k–$1.9M
Wolfgang Schuch
Angel
1 Chile Seed Farming, Chemical, Agriculture
Guilherme Leal
Angel
1 Brazil Series A Chemical, Biopharma, Biotechnology
Mark Gormley
Angel
1 United States, Canada Private Equity, Series A, Secondary Market Insurance, Risk Management, Service Industry
Fabricio Bloisi
Angel
1 Brazil, Colombia, Argentina Series A, Seed, Angel Software, E-Commerce, SaaS $4M–$10M
Steve Zurcher
Angel
1 Argentina Seed Biopharma, Biotechnology, Food Processing
Martin Torres Cava
Angel
1 Peru Pre-Seed Medical, Wellness, Health Care
Matt Cutts
Angel
1 United States, Canada, Mexico Seed, Angel, Series A SaaS, Health Care, Medical $493k–$2.8M
Jeff Horing
Angel
1 United States, Israel, Canada Series B, Series A, Series C Software, Artificial Intelligence, Information Technology $8.7M–$210M
Elizabeth Iorns
Angel
1 United States, Canada, Mexico Seed, Pre-Seed Software, SaaS, Health Care $1.9M–$3M
Martin Anazco
Angel
1 United States, Spain, Argentina Seed, Pre-Seed Machine Learning, Apps, Gaming $550k–$3.3M
Diego Meller
Angel
1 United States, Spain, Argentina Seed, Pre-Seed Machine Learning, Apps, Gaming $550k–$3.3M
Pedro Arnt
Angel
1 Mexico, Uruguay, Colombia Series A, Seed, Angel Software, Information Technology, Financial Services $1.1M–$20M
Shirleyson Kaisser
Angel
1 Brazil Pre-Seed Biotechnology, Personal Health, Plastics and Rubber Manufacturing
Tim Draper
Angel
1 United States, United Kingdom, Canada Seed, Series A, Series B Software, FinTech, Financial Services $356k–$50M
Dan Knox
Angel
1 Mexico, United States Seed Finance, Health Care, Crowdfunding
Allen Miner
Angel
1 Japan, United States, Singapore Seed, Series B Software, Food and Beverage, Information Technology $600k–$20M
Jun Ueki
Angel
1 Argentina Seed Biopharma, Biotechnology, Food Processing
Mat Travizano
Angel
1 Argentina, Spain Seed, Series A PaaS, Bitcoin, FinTech $3.6M–$6.4M
Paul Buchheit
Angel
1 United States, Canada, India Seed, Series A, Angel Software, Artificial Intelligence, E-Commerce $100k–$14M
Sergio Fogel
Angel
1 Uruguay, Israel, Brazil Seed, Pre-Seed, Venture - Series Unknown Software, Financial Services, CRM $1.5M–$12M
Eric Urhane
Angel
1 United States, Mexico, Singapore Seed, Angel Software, Health Care, Biotechnology $1.1M–$1.9M
Armínio Fraga
Angel
1 Brazil Seed, Pre-Seed, Series A EdTech, Education, Recruiting
Bob Goodman
Angel
1 United States, Israel, Germany Series B, Series C, Series D Software, SaaS, Enterprise Software $7M–$410M
Sohail Prasad
Angel
1 United States, France, Mexico Seed, Series A Software, Human Resources, Financial Services $1.1M–$25M
Geoffrey KALISH
Angel
1 United States Series A AgTech, Seafood, Biotechnology
Eduardo Mufarej
Angel
1 Brazil, Colombia, United States Seed, Pre-Seed, Series C EdTech, Life Science, Biotechnology $1M–$2M
Isabella Prata
Angel
1 Brazil Angel GreenTech, Biotechnology, Natural Resources
Francisco Miranda
Angel
1 Chile Seed Biotechnology, Food Processing, Meat and Poultry
Cory Levy
Angel
1 United States, Canada, United Kingdom Pre-Seed, Seed, Series A Artificial Intelligence, Software, Advertising $200k–$72M
Ashton Kutcher
Angel
1 United States, Germany, Canada Seed, Series A, Series B Software, E-Commerce, Apps
Access all 40 angel investors in LATAM Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Kevin Efrusy
Angel · Palo Alto, California, United States · 2 investments in LATAM Biotech startups

Kevin Efrusy is the Co-Founder of The Efrusy Family Foundation and a Partner at Accel. Prior to that, he was the CEO and board member, and co-founder of IronPlanet. He attended Stanford University Graduate School of Business and Stanford University.

Show more...

Investment focus

  • Industry: Software, E-Commerce, FinTech
  • Stage:Series B, Series A, Series C
  • Geography: Brazil, United States, Mexico

Investor stats

  • Total investments: 73
  • Round size: Series A $6M–$30M; Series B $10M–$35M; Series C $11M–$100M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Azos — Azos is an insurtech firm that offers best in class insurance life insurance products in the Brazilian market. The company was founded by Rafael Cló, Bernardo Ribeiro, and Renato Farias and is headquartered in Sao Paulo, Brazil.
  • Sami — Sami is a Brazil-based health plan startup that provides a technology-based solution intended to be used in the healthcare sector. The company focuses on making health care simpler, more efficient, and friendlier by using simplified solutions, thus, providing patients with reduced costs for their medical care needs. Their mission is to transformBrazilian health into something simple, easy, reliable, and accessible, which helps each person to be their best version.Founded by Vitor Asseituno and Luiz Guilherme Berardo in 2018 and is based in São Paulo, Brazil.
  • Lerian — Lerian is a next-gen core banking platform built on top of an open source ledger.
Show all investments...

Pablo Pla
Angel · 1 investments in LATAM Biotech startups

Pablo Pla is the Chief Executive Officer of San Miguel. He Previously worked at Ingredion Incorporated as a President and General Manager. Pablo Pla attended Columbia Business School.

Show more...

Investment focus

  • Industry: Biopharma, Biotechnology, Food Processing
  • Stage:Seed
  • Geography: Argentina

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
Show all investments...

Franco Goytia
Angel · 1 investments in LATAM Biotech startups

CEO @ CellCo Co-Founder & CEO @ CASPR Biotech

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Argentina

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • OncoPrecision — We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity and Resistance Test, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access toPrecision Oncology and improve cancer patients' lives.
Show all investments...

Ignacio Smith
Angel · 1 investments in LATAM Biotech startups

Ignacio Smith

Show more...

Investment focus

  • Industry: Farming, Chemical, Agriculture
  • Stage:Seed
  • Geography: Chile

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Botanical Solutions — BSI produces plant-based biofungicides for sustainable agriculture & advanced botanical materials for the gold standard vaccine adjuvant QS-21
Show all investments...

Daniel Gold
Angel · 1 investments in LATAM Biotech startups

Daniel Gold

Show more...

Investment focus

  • Industry: Genetics, Life Science, Biotechnology
  • Stage:Pre-Seed
  • Geography: Brazil

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • gen-t — Gen-t is a platform capable of providing the map of genomic research. Gen-t was founded in 2021 and was headquartered in Sao Paulo, Brazil.
Show all investments...

Nadav Ben-Chanoch
Angel · Miami, Florida, United States · 1 investments in LATAM Biotech startups

Nadav Ben-Chanoch

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 226
  • Round size: Seed $500k–$6M; Pre-Seed $120k–$2.5M; Series A $4M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • micro1 — We help companies hire and manage the best software engineers easily.
  • TRIVER — Triver develops online and digital tools to assist and support various financial services. It is based in London, England.
  • Skedway — The optimization hub for the Modern Enterprise - Visualize, integrate and manage every shared company asset in one place.
Show all investments...

Edward Lando
Angel · San Francisco, California, United States · 1 investments in LATAM Biotech startups

Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 478
  • Round size: Seed $975k–$7M; Pre-Seed $125k–$3.4M; Series A $5.5M–$37M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Humera — Humera - AI CAPTCHA That Knows You're Human
  • Allonic — Allonic is a robotics hardware company pioneering 3D Tissue Braiding, a new manufacturing platform for producing integrated, compliant, bio-inspired robotic bodies through a single, fully automated production process. By eliminating assembly-heavy designs and supply-chain complexity, Allonic enables significantly faster iteration, lower costs, andsafer, more dexterous robots to be built. Originally founded from Hungary and operating internationally with a US HQ and a growing team of 15, Allonic is building the hardware foundation for the next generation of intelligent machines.
  • Heywa Labs — Heywa Labs develops Generative UX (GenUX), an AI-driven interface layer that creates dynamic, adaptive user experiences beyond static text or links. Their flagship app, Heywa, delivers visual, tappable "stories" of cards for tasks like cooking, travel, fitness, and DIY, reconfiguring in real-time based on user interactions.
Show all investments...

Robert Stavis
Angel · New York, New York, United States · 1 investments in LATAM Biotech startups

Robert Michael Stavis is based out of Larchmont, New York and is the Partner of Bessemer Venture Partners. Robert previously worked at NewSchools Venture Fund as a Director. Robert Stavis attended the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Finance
  • Stage:Series C, Series B, Series A
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 35
  • Round size: Series A $3.9M–$38M; Series B $9.3M–$126M; Series C $10M–$32M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • LNTS — LNTS has recognized the deficiencies in healthcare and through our proprietary technology and solution, we are making rehabilitation and performance far more efficient for patients, clinicians and providers. LNTSConnect.com
  • Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
  • Flower Company — We sell weed on the internet. Thousands of products delivered overnight throughout California from Humboldt to San Diego
Show all investments...

Peter Andersen
Angel · Walnut Creek, California, United States · 1 investments in LATAM Biotech startups

Peter Andersen

Show more...

Investment focus

  • Industry: Chemical, Biopharma, Biotechnology
  • Stage:Series A
  • Geography: Brazil

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Nintx — Next Innovative Therapeutics involves advancing therapies to the end of preclinical studies, and Nintx develops therapies targeting biological pathways directly and indirectly through gut microbiome modulation.
Show all investments...

Thomas James
Angel · 1 investments in LATAM Biotech startups

Thomas James

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Mexico

Investor stats

  • Total investments: 2
  • Round size: Seed $52k–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • Miproto — Miproto is changing manufacturing for both businesses and individuals. The website allows anybody to upload their product idea, and have it developed by the same engineers working on the worlds most advanced technologies, into 3D CAD files, 3D printed models, prototypes and even mass manufactured items.The company brings together the disjointedprocess into one slick system – reducing times from months to days and weeks. Whilst reducing costs by cutting admin roles and multiple projects managers across facilities.Miproto provides a platform for product design that connects in house engineers with a global army of 24/7 freelancers, client projects, CAD files, 3D printing machines, CNC factories, mass manufacturing facilities, and even a 2D printer for invoicing!Whilst Student, Joey McConnel, was able to develop his university project component into a manufactured piece, the Design Council used Miproto to design and 3D print 200 awards for the designers involved in the London 2012 Olympics. At the same time, top secret medical devices where being prototyped in the London 3D printers. These were being designed over night by a selection of client chosen freelance engineers, based in America and Asia.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Wolfgang Schuch
Angel · 1 investments in LATAM Biotech startups

Wolfgang Schuch

Show more...

Investment focus

  • Industry: Farming, Chemical, Agriculture
  • Stage:Seed
  • Geography: Chile

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Botanical Solutions — BSI produces plant-based biofungicides for sustainable agriculture & advanced botanical materials for the gold standard vaccine adjuvant QS-21
Show all investments...

Guilherme Leal
Angel · 1 investments in LATAM Biotech startups

Guilherme Leal is the founder of Arapyaú.

Show more...

Investment focus

  • Industry: Chemical, Biopharma, Biotechnology
  • Stage:Series A
  • Geography: Brazil

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Nintx — Next Innovative Therapeutics involves advancing therapies to the end of preclinical studies, and Nintx develops therapies targeting biological pathways directly and indirectly through gut microbiome modulation.
Show all investments...

Mark Gormley
Angel · New York, New York, United States · 1 investments in LATAM Biotech startups

Mark K. Gormley is a Partner at Lee Equity Partners. Prior to joining Lee Equity in 2006, Mr. Gormley was a Partner at Capital Z Financial Services Partners (“CZFS”), a leading financial services private equity firm, where he played a leading role in the operations and investment activities of the $1.85 billion fund. Mr. Gormley co-founded CZFS in1998 and shared responsibility for the oversight of all of the firm's investment and monitoring activities. Prior to founding CZFS, Mr. Gormley served as a Managing Director at Donaldson, Lufkin & Jenrette (“DLJ”), specializing in the insurance and asset management industries. While at DLJ, Mr. Gormley worked on corporate finance and merger and acquisition assignments, as well as on principal related activities on behalf of DLJ Merchant Banking. Prior to joining DLJ in 1989, he was a founding member of the Insurance Group at Merrill Lynch in 1985. Mr. Gormley serves or has served as a director of numerous public and private companies, including The Edelman Financial Group, Skopos Financial Group, Captive Resources, Carlile Bancshares, PDR Network, MidCap Financial, Universal American, Permanent General, NewStar Financial, British Marine Holdings, Catlin Group, Bank Handlowy, Ceska Sporitelna, NACOLAH among others. Mr. Gormley received a B.S.B.A. cum laude in Finance and Economics from the University of Denver and an M.B.A. from New York University.

Show more...

Investment focus

  • Industry: Insurance, Risk Management, Service Industry
  • Stage:Private Equity, Series A, Secondary Market
  • Geography: United States, Canada

Investor stats

  • Total investments: 5
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
  • Axis Insurance — Axis Insurance stands at the forefront of the insurance industry, drawing on decades of expertise and a forward-thinking approach.
  • Pure Financial Advisors — Pure Financial Advisors provides financial advice for pre-retirees and retirees. Michael Fenison and Paul M. Miller founded it in 2007, with its headquarters in San Diego in California.
Show all investments...

Fabricio Bloisi
Angel · 1 investments in LATAM Biotech startups

Fabricio Bloisi is the CEO of Prosus Group. He previously worked at iFood as a CEO. Fabricio Bloisi attended Harvard Business School.

Show more...

Investment focus

  • Industry: Software, E-Commerce, SaaS
  • Stage:Series A, Seed, Angel
  • Geography: Brazil, Colombia, Argentina

Investor stats

  • Total investments: 8
  • Round size: Series A $4M–$10M
  • Lead/follow: 88% lead, 12% follow

Portfolio highlights

  • Sympla — Sympla is Brazil's leading self-service ticketing and event management platform.The company has been created to empower event organizers by providing them with a complete set of tools that facilitate ticket selling and managing each stage of their events.Sympla is used all over Brazil to sell and manage music concerts, sports events,conferences, seminars, courses, workshops and many other types of events.
  • BioLinker — BioLinker is a production of synthetic biology, protein synthesis kits, and protein.
  • Voa Health — Voa's purpose is to become the primary enabler of AI-enhanced healthcare.
Show all investments...

Steve Zurcher
Angel · San Francisco, California, United States · 1 investments in LATAM Biotech startups

Steve Zurcher

Show more...

Investment focus

  • Industry: Biopharma, Biotechnology, Food Processing
  • Stage:Seed
  • Geography: Argentina

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
Show all investments...

Martin Torres Cava
Angel · Lima, Lima, Peru · 1 investments in LATAM Biotech startups

Doctor specialized in Diagnostic Imaging with more than 25 years of experience, also specialized in Breast Radiology, Occupational Health and Health Management, as well as in technological developments

Show more...

Investment focus

  • Industry: Medical, Wellness, Health Care
  • Stage:Pre-Seed
  • Geography: Peru

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Veo365 — Veo365 is a mobile/desktop solution for medical monitoring, occupational health, epidemiological surveillance, health education/prevention and real-time operational standards for companies, organizations, and in general for communities and governments. Their digital solution also integrates wearables and machine learning for a betterhealth diagnostic experience.Veo365 is headquartered in Lima, Peru and was founded in 2019.
Show all investments...

Matt Cutts
Angel · San Francisco, California, United States · 1 investments in LATAM Biotech startups

Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his

Show more...

Investment focus

  • Industry: SaaS, Health Care, Medical
  • Stage:Seed, Angel, Series A
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 11
  • Round size: Seed $493k–$2.8M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • X-ZELL — Early, pain-free cancer cell detection
  • Meter Feeder — Easily pay for parking through MeterFeeder
Show all investments...

Jeff Horing
Angel · New York, New York, United States · 1 investments in LATAM Biotech startups, 10 in the past 12 months

Jeff Horing is based out of New York, New York and is the Managing Director of Insight Partners. Jeff previously worked at E.M. Warburg, Pincus & Co as a Team Member. Jeff Horing attended the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 91
  • Round size: Series A $8.7M–$125M; Series B $24M–$115M; Series C $42M–$210M
  • Lead/follow: 78% lead, 22% follow

Portfolio highlights

  • FloVision Solutions — Food Analytics to maximize profits and minimize waste. FloWaste allows food service providers to optimize meal preparation, ingredient combinations, and portion sizing
  • Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
  • Airis Labs — Airis Labs provides a platform that turns user-generated content into field intelligence. The system extracts information from videos, images, audio, and text to help identify threats. It processes large amounts of unstructured data to support investigations and monitoring. The platform reduces time spent reviewing footage by automating theanalysis process. It offers high accuracy in locating urban areas from visual data. Airis combines multiple tools into one system for intelligence gathering and threat mapping. The platform can be deployed on private servers or through cloud networks.
Show all investments...

Elizabeth Iorns
Angel · Palo Alto, California, United States · 1 investments in LATAM Biotech startups

Elizabeth Iorns is the Co-Founder, President, and CEO of Science Exchange. She previously worked at Y Combinator as a Part-time partner. Elizabeth Iorns attended the University of Auckland.

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 6
  • Round size: Seed $1.9M–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Torch — Transform your organization with Torch's leadership development solutions and drive lasting sustainable change.
  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • Enzyme — Enzyme QMS software includes modules for all stages of the product development life cycle from Design Control to CAPA. Our in-house experts are here to back you up! We can guide you through the quality challenges and regulatory submission process. Sign up for a Demo today.
Show all investments...

Martin Anazco
Angel · San Francisco, California, United States · 1 investments in LATAM Biotech startups

Martin co-founded Jampp in 2011 - a mobile app marketing platform that combines advanced technology (Big Data, Real Time Bidding and Machine Learning) with a team of mobile marketing experts to deliver millions of users to iOS and Android apps globally. Previously, in the year 2000, he co-founded and ran Livra.com (Livra Panels) which becamethe leading online market research company in Latin America. In 2008, after continuous growth the company was acquired by publicly listed IPSOS - one of the top market research organisations world-wide.Martin was born in Comodoro Rivadavia, Argentina. He graduated in Economics from the University of San Andres in Buenos Aires (Honors Thesis: "Selling Information Good on the Internet: Give before you sell").

Show more...

Investment focus

  • Industry: Machine Learning, Apps, Gaming
  • Stage:Seed, Pre-Seed
  • Geography: United States, Spain, Argentina

Investor stats

  • Total investments: 4
  • Round size: Seed $550k–$3.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Jampp — Jampp is the programmatic platform to grow mobile apps. We leverage machine learning to unlock mobile marketing and drive incremental ROI.
  • GetGloby — GetGloby is an AI-powered platform that allows you to automatically localize your ads in minutes and manage all your translations effortlessly.
  • OncoPrecision — We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity and Resistance Test, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access toPrecision Oncology and improve cancer patients' lives.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Diego Meller
Angel · San Francisco, California, United States · 1 investments in LATAM Biotech startups

Diego co-founded Jampp in 2013 - The company is a performance marketing platform for retargeting and acquiring app customers. The company combines behavioural data with predictive and programmatic technology to generate revenue for advertisers by showing personal, relevant ads that inspire consumers to purchase for the first time, or more often.Jampp's 90 people team serve a global client base from offices in San Francisco, Singapore, London, Berlin, São Paulo, Cape Town and Buenos Aires. Previously, in the year 2000, Diego co-founded and ran Livra.com which became the leading online market research company in Latin America. In 2008, after continuous growth the company was acquired by publicly listed IPSOS - one of the top market research organisations world-wide.

Show more...

Investment focus

  • Industry: Machine Learning, Apps, Gaming
  • Stage:Seed, Pre-Seed
  • Geography: United States, Spain, Argentina

Investor stats

  • Total investments: 4
  • Round size: Seed $550k–$3.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Jampp — Jampp is the programmatic platform to grow mobile apps. We leverage machine learning to unlock mobile marketing and drive incremental ROI.
  • GetGloby — GetGloby is an AI-powered platform that allows you to automatically localize your ads in minutes and manage all your translations effortlessly.
  • OncoPrecision — We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity and Resistance Test, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access toPrecision Oncology and improve cancer patients' lives.
Show all investments...

Pedro Arnt
Angel · 1 investments in LATAM Biotech startups

Pedro Arnt is the current Co-Chief Executive Officer of dLocal. He previously worked at MercadoLibre as a Chief Financial Officer and Executive Vice President. Pedro Arnt attended the University of Oxford.

Show more...

Investment focus

  • Industry: Software, Information Technology, Financial Services
  • Stage:Series A, Seed, Angel
  • Geography: Mexico, Uruguay, Colombia

Investor stats

  • Total investments: 6
  • Round size: Seed $1.1M–$2.6M; Series A $15M–$20M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Mendel — Mendel is a provider of financial technology that intends to make businesses save money and spend less.
  • CellRep — Transforming the Future of Cell Therapies.
  • Data4Sales — We help eCommerce stores to understand their most valuable customers. Our A.I. recommends actionable insights that help you treat customers differently on every channel, improving retention, acquisition and developing customer value.Create a passionate, committed customer base that will spread the word of your eCommerce store attributes topotential new customers. As a result, we help you make far more money from your most valuable customers, who will buy from you more often and spend more when purchasing from you.
Show all investments...

Shirleyson Kaisser
Angel · 1 investments in LATAM Biotech startups

Investment focus

  • Industry: Biotechnology, Personal Health, Plastics and Rubber Manufacturing
  • Stage:Pre-Seed
  • Geography: Brazil

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Jhope — JHOPE is Umbrella Branding that controls the production and commercialization of products related to the fight against viruses and bacteria, bringing hygiene and protection to the world. An innovative patent-required solution to stop virus and bacteria spreading.
Show all investments...

Tim Draper
Angel · San Francisco, California, United States · 1 investments in LATAM Biotech startups, 18 in the past 12 months

Tim Draper is the Founding Partner of Draper Associates. He attended Harvard Business School.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 298
  • Round size: Seed $356k–$6.5M; Series A $2.5M–$25M; Series B $3M–$50M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • CASIMIR
  • illumicell AI — illumicell AI combines patented AI algorithms and proprietary microscopy technology to test 50x faster, 20x more effectively, empowering every healthcare provider at the point of care – not just fertility clinics – with accessible, scalable fertility diagnostics.
  • SignalRank — SignalRank Corporation is a FinTech company in the Venture space. It focuses on the seed stage asset class and uses data analytics to allocate capital to the best seed fund managers for their top performing companies. GPRank and CompanyRank are two proprietary algorithms it leverages to automate capital allocation. The company invests from balancesheet. Its customers are seed stage investors with outstanding companies in their portfolio.
Show all investments...

Dan Knox
Angel · San Francisco, California, United States · 1 investments in LATAM Biotech startups

Dan Knox is one of the founders of Science Exchange, an online marketplace for science experiments. Prior to founding Science Exchange, Dan was Head of Operations at DailyMe, a pioneer in the field of dynamic personalization and predictive content and commerce presentation. Before joining DailyMe, Dan was Head of Economic Analysis within in theStrategy team at a leading commercial television network in the U.K., and a Senior Economist in the Media & Communications group of a global expert services consulting firm.Dan was part of the inaugural Executive MBA class at MIT Sloan School of Management. He also has a Master's degree and a Bachelor's degree in Economics, a Law degree and the Chartered Financial Analyst (CFA) qualification.

Show more...

Investment focus

  • Industry: Finance, Health Care, Crowdfunding
  • Stage:Seed
  • Geography: Mexico, United States

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • Experiment — Experiment is an online community and a crowdfunding platform for scientific research. It provides crowdfunding services for scientific research related to categories such as biology, chemistry, computer science, medicine, anthropology, psychology, engineering, and more.The platform provides its services for researchers from over 150institutions and universities around the world. It is in strategic partnerships with Experiment was founded by
Show all investments...

Allen Miner
Angel · Tokyo, Tokyo, Japan · 1 investments in LATAM Biotech startups

Allen Miner is a founder/General Partner of SunBridge Partners and the founder/CEO of SunBridge Corporation. Allen has significant experience in Internet, enterprise and open-source software, entrepreneurship, and international technology transfer. Allen has been actively involved in each of the firm’s investments resulting in numeroussuccessful IPOs, including salesforce.com, MacroMill, ITMedia and G-Mode, among others. Allen is currently a member of the Board of Directors of salesforce Japan.Allen graduated from Brigham Young University with degrees in Computer Science and Asian Studies. He joined Oracle Corporation in 1986 and was dispatched to Japan, where he founded and helped lead Oracle Japan to a successful IPO on the Japan stock market. Allen returned from Japan in 1996 to serve as Oracle’s Vice President in charge of Linux/Open Source.Allen created SunBridge Corporation in 1999. Allen currently serves on the Boards of several SunBridge portfolio companies and as an advisor to government-affiliated organizations focused on innovation and entrepreneurship. He was appointed to the Board of Directors of the Japan Venture Capital Association upon its founding in 2002.

Show more...

Investment focus

  • Industry: Software, Food and Beverage, Information Technology
  • Stage:Seed, Series B
  • Geography: Japan, United States, Singapore

Investor stats

  • Total investments: 38
  • Round size: Seed $600k–$16M; Series B $3.1M–$20M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • U-ZERO — U-ZERO provides services as an integrated partner for its implementation and establishment.
  • Favy — Favy is a platform that enables businesses such as restaurants and beauty salons to launch subscription services.
  • BONAVENTURA — BONAVENTURA is a luxury leather goods brand redefining the essence of next-generation luxury under the vision of 'Beyond Luxury,' combining a robust e-commerce foundation with an expanding network of retail stores.Embark on life's journey with BONAVENTURA, where Italian craftsmanship meets timeless design. Blending elegance,functionality, and premium materials, our creations are crafted to bring lasting joy and stand the test of time.The name "BONAVENTURA" and our symbol "Infinity Clover' symbolize good luck and eternal happiness for those who cherish life’s moments.
Show all investments...

Jun Ueki
Angel · 1 investments in LATAM Biotech startups

Jun Ueki is the CEO at Keiretsu Forum Japan.

Show more...

Investment focus

  • Industry: Biopharma, Biotechnology, Food Processing
  • Stage:Seed
  • Geography: Argentina

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CarLabs — It is an Automotive AI startup dedicated to rethinking the way people buy, sell, finance, insure and maintain their cars. It is the creator of Carla, the world’s first conversational agent for all things automotive. Carla uses a proprietary API that helps translate user needs into data sets and complex data into user friendly language. It is thecar expert you’ve always needed on hand, only smarter
  • Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
Show all investments...

Mat Travizano
Angel · San Francisco Bay Area, California, United States · 1 investments in LATAM Biotech startups

Mat Travizano is the Founder & Chairman at GranData.

Show more...

Investment focus

  • Industry: PaaS, Bitcoin, FinTech
  • Stage:Seed, Series A
  • Geography: Argentina, Spain

Investor stats

  • Total investments: 3
  • Round size: Seed $3.6M–$6.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
  • Reloadly — Send gift cards, airtime & payouts globally with one API. Scalable, instant, developer-friendly platform for rewards and incentives.
  • SenseiNode — We drive the decentralization of the blockchain ecosystem in Latin America with a simple, scalable and secure node management platform.
Show all investments...

Paul Buchheit
Angel · Mountain View, California, United States · 1 investments in LATAM Biotech startups

Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, E-Commerce
  • Stage:Seed, Series A, Angel
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 153
  • Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$14M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
  • BuildForever — BuildForever build products that feel personal, magical and deeply human.
  • Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Show all investments...

Sergio Fogel
Angel · Montevideo, NA - Uruguay, Uruguay · 1 investments in LATAM Biotech startups

Experienced Latin American internet entrepreneur. Co-founder and CEO, Astropay LLP. Organizer, Punta Tech Meetup. Sergio Fogel is one of the most recognized internet entrepreneurs in Uruguay and in Latin America in general. He founded several companies, among them Astropay (the leading alternative payments processor in Latam), Uniotel (LongDistance Carrier in Uruguay) and JetNumbers.com. Sergio is also the original founder and organizer of Punta Tech Meetup, a gathering of tech entrepreneurs held every January in Punta del Este, Uruguay. Sergio holds an MBA from INSEAD and a master's degree in computer science from the Technion. He previously worked as reseracher in IBM's Haifa Research Labs, as well as in sales for Oracle Corp.

Show more...

Investment focus

  • Industry: Software, Financial Services, CRM
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: Uruguay, Israel, Brazil

Investor stats

  • Total investments: 9
  • Round size: Seed $1.5M–$12M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Latitud — Build good sh*t with Latitud
  • Data4Sales — We help eCommerce stores to understand their most valuable customers. Our A.I. recommends actionable insights that help you treat customers differently on every channel, improving retention, acquisition and developing customer value.Create a passionate, committed customer base that will spread the word of your eCommerce store attributes topotential new customers. As a result, we help you make far more money from your most valuable customers, who will buy from you more often and spend more when purchasing from you.
  • Xeptiva Therapeutics — Xeptiva Therapeutics is an innovative biotech that develops novel therapies for the veterinary market
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Eric Urhane
Angel · 1 investments in LATAM Biotech startups

Eric Urhane

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Angel
  • Geography: United States, Mexico, Singapore

Investor stats

  • Total investments: 5
  • Round size: Seed $1.1M–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • X-ZELL — Early, pain-free cancer cell detection
  • Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.
Show all investments...

Armínio Fraga
Angel · Rio De Janeiro, Rio de Janeiro, Brazil · 1 investments in LATAM Biotech startups

Armínio Fraga

Show more...

Investment focus

  • Industry: EdTech, Education, Recruiting
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Brazil

Investor stats

  • Total investments: 4
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • gen-t — Gen-t is a platform capable of providing the map of genomic research. Gen-t was founded in 2021 and was headquartered in Sao Paulo, Brazil.
  • Jobecam — Jobecam is a SaaS - B2B platform that helps companies to reduce unconscious bias through anonymized video interviews (pre-recorded or live) and resumes, while also helping to optimize the recruitment and selection process itself. Jobecam technology, which can be used native or integrated with any HR system, applies Artificial Intelligence (AI) toanonymize interviews from candidates. The interviews are then presented to the recruiters with an unidentifiable image (an avatar) and an altered voice (not gendered). The candidates will only be revealed after being promoted to the following phase. The technology also allows real time interactions with the evaluators in the case of live interviews, where candidates are anonymized through robotic voices, image represented by an avatar and to be named in relation with cities or countries.We are supported by Oracle, Estação Hack Facebook Google for startups, BR and Harvard Angels Brazil, IDB Labs, and othersLearn more at www.jobecam.com
  • Galena — Galena is a company that specializes in providing a centralized platform for professional development, targeting HR professionals in medium to large companies. Their platform offers access to a variety of external courses, tailored to the development needs and aspirations of individual employees. This approach simplifies operational processes forHR departments, enhancing strategic engagement and development management through data intelligence. Galena focuses on delivering individualized learning solutions on a scalable level, aiding in the professional growth and development of employees.
Show all investments...

Bob Goodman
Angel · New York, New York, United States · 1 investments in LATAM Biotech startups

Robert Goodman is a general partner at Goodman served as a director at he joined Bessemer Venture Partners. He has also worked at Goodman holds a bachelor’s degree in arts from

Show more...

Investment focus

  • Industry: Software, SaaS, Enterprise Software
  • Stage:Series B, Series C, Series D
  • Geography: United States, Israel, Germany

Investor stats

  • Total investments: 36
  • Round size: Series B $10M–$40M; Series C $15M–$100M; Series D $7M–$410M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • cargo.one — The cargo.one booking platform gives you access to real-time prices and available capacities of multiple airlines. Directly book online within seconds, 24/7.
  • DriveNets — DriveNets is a fast-growing IP networking software company that revolutionizes Communications Service Provider (CSP) networks by disaggregating the network infrastructure from core to edge, similar to the way hyperscalers have disaggregated the cloud. DriveNets Network Cloud is an open distributed disaggregated networking solution based oncloud-native software and standard networking white boxes.The company was founded in 2016 by Ido Susan and Hillel.
  • Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
Show all investments...

Sohail Prasad
Angel · San Francisco, California, United States · 1 investments in LATAM Biotech startups

Sohail is the Founder & CEO of Destiny (D/XYZ).Sohail is also Founder & former Co-CEO of Forge, the stock market for private companies. He has an extensive background in product management, engineering, and business. As an eighteen-year-old, he was among the youngest founders to go through Y Combinator. Over the years, Sohail hasadvised and invested in over 100 startups, including notable startups such as Zenefits and Rappi. He continues to invest actively through S2 Capital, and serves as its Founding Partner. Prior to founding Equidate, Sohail managed mobile product at Zynga. He previously joined mobile advertising firm Chartboost as its second engineering hire, and has held roles at Google and the MIT Media Lab. Sohail was awarded TCU's Texas Youth Entrepreneur of the Year award in 2010, and was later named a Thiel Fellow by the Thiel Foundation. He previously attended Carnegie Mellon University where he studied Electrical & Computer Engineering.

Show more...

Investment focus

  • Industry: Software, Human Resources, Financial Services
  • Stage:Seed, Series A
  • Geography: United States, France, Mexico

Investor stats

  • Total investments: 12
  • Round size: Seed $1.1M–$7M; Series A $11M–$25M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • Wethenew — Acquistate le vostre autentiche sneakers prodotti streetwear in edizione limitata in modo sicuro e protetto su wethenew.com!
  • Series — Series provides full-stack enterprise financial services designed for institutions & enterprises.
Show all investments...

Geoffrey KALISH
Angel · New York, New York, United States · 1 investments in LATAM Biotech startups

Mr. Kalish is a Partner & Chief Operating Officer at Aquiline Capital Partners.Previously, Mr. Kalish was also the Founder and Managing Director at Venturion Capital. He has served on the boards of numerous financial services companies in Europe and the US. He holds a history degree from Columbia and a masters degree in public policy fromHarvard.

Show more...

Investment focus

  • Industry: AgTech, Seafood, Biotechnology
  • Stage:Series A
  • Geography: United States

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
Show all investments...

Eduardo Mufarej
Angel · São Paulo, Sao Paulo, Brazil · 1 investments in LATAM Biotech startups

Eduardo Mufarej built his career in private equity and education as an investor and entrepreneur. He co-founded and was CEO of Tarpon Investimentos, one of Brazil’s largest independent investment managers. He served on several boards and was Chairman of Somos Educação and Omega Energia Renovável. From 2014 until 2018 Eduardo led the largest k-12company in Latin America, Abril Educação, which he managed until the sale of the company to Kroton Educacional in October 2018. After the sale, Eduardo created Renova, a project focused on selecting and training a new generation of leaders in Brazilian politics. Since its creation, the program has supported and trained over 2000 individuals in Brazil, helping to elect 176 of its students. This effort awarded Eduardo the prize Brazilian Entrepreneur of the Year in 2018. In early 2020, Eduardo co-founded Galena, a company that supports and trains individuals for their first jobs. Eduardo is a member of the advisory board of the Wilson Institute, in Washington, DC, of the Yale University SOM Council of Global Advisors and a fellow at Stanford’s Graduate School of Education.  He is the author of the book Jornada Improvável (Unlikely Journey, 2021).

Show more...

Investment focus

  • Industry: EdTech, Life Science, Biotechnology
  • Stage:Seed, Pre-Seed, Series C
  • Geography: Brazil, Colombia, United States

Investor stats

  • Total investments: 5
  • Round size: Seed $1M–$2M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • gen-t — Gen-t is a platform capable of providing the map of genomic research. Gen-t was founded in 2021 and was headquartered in Sao Paulo, Brazil.
  • HUNTY — HUNTY is a platform that help people find jobs by connecting them with world class mentors who prepare them for the job search process. And people only pay when they get hired.
  • Alicerce — Alicerce is a social impact platform designed to support middle-class education. It offers an educational solution, focused on what is most important and promotes the social ascension of Brazilian families.The company is driven by a mission to provide a successful opportunity for all young Brazilians through quality education.Alicerce wasfounded in 2017 and is headquartered in Sao Paulo, Brazil.
Show all investments...

Isabella Prata
Angel · 1 investments in LATAM Biotech startups

Isabella Prata

Show more...

Investment focus

  • Industry: GreenTech, Biotechnology, Natural Resources
  • Stage:Angel
  • Geography: Brazil

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MABE Bio — Mabe Bio is a biotech solutions that combines technology and nature to create new materials from plants by investigating the potential of Brazilian biodiversity.
Show all investments...

Francisco Miranda
Angel · Santiago, Region Metropolitana, Chile · 1 investments in LATAM Biotech startups

CEO of San Pablo Alimentos

Show more...

Investment focus

  • Industry: Biotechnology, Food Processing, Meat and Poultry
  • Stage:Seed
  • Geography: Chile

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • BeeTechnology — Biotech StartUp developing active ingredients for food to extend shelf-life, increase food quality and safety, with an organic approach
Show all investments...

Cory Levy
Angel · San Francisco, California, United States · 1 investments in LATAM Biotech startups

Cory Levy is the Founder of Z Fellows. He previously worked at DoSomething.org as a Board Member. Cory attended University of Illinois Urbana-Champaign, where he took Computer Science.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Advertising
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 75
  • Round size: Seed $1.1M–$11M; Pre-Seed $200k–$3.3M; Series A $14M–$72M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Wander — Never book a bad vacation home again. Every Wander comes with hotel-grade amenities, inspiring views, pristine cleaning and 24/7 concierge service.
  • Pilgrim — Pioneering a biologically enhanced future for humanity.
  • Swish Robotics — Embodied Intelligence for the Home
Show all investments...

Ashton Kutcher
Angel · Los Angeles, California, United States · 1 investments in LATAM Biotech startups

Ashton Kutcher is an actor, investor, entrepreneur, producer and philanthropist.Kutcher has been named one of TIME magazine’s “100 Most Influential People in the World,” as well as being honored by Vanity Fair ‘s “New Establishment List,” which identifies the top 50 of an innovative new breed of buccaneering visionaries, engineering prodigiesand entrepreneurs. Twice, Kutcher was named one of Forbes magazine’s “World’s Most Powerful Celebrities,” as well as one of Fast Company magazine’s “Most Creative People.”Kutcher has been investing in technology for over a decade, both as an angel investor and a founding partner of A-Grade Investments and Sound Ventures. His fund portfolio includes Airbnb, Uber, Flexport, Brex, Robinhood, Bird, Airtable and Affirm among others.Kutcher is also the co-founder of Thorn: Digital Defenders of Children (www.thorn.org). Thorn drives technology innovation to fight the sexual exploitation of children.Kutcher currently stars in the Netflix original series, The Ranch. He also serves as Executive Producer. Until 2015, Kutcher starred in the CBS comedy series Two and a Half Men. The show ranked as the second most-watched comedy on all of network television. Kutcher first gained recognition as Michael Kelso on the Fox series That 70’s Show, and went on to star in a variety of box office hits on the big screen – including What Happens In Vegas with Cameron Diaz, The Guardian with Kevin Costner, No Strings Attached with Natalie Portman and the cult hit Dude, Where’s My Car.Kutcher served as co-creator and producer of MTV's hit series, “Punk'd,” and The CW's reality series “Beauty and the Geek” and “True Beauty.” He has also produced films such as No Strings Attached, Killers and The Butterfly Effect. Additionally, Kutcher co-founded APlus, a digital media company devoted to spreading the message of positive journalism, a kind of storytelling that focuses on our shared humanity. In 2016, APlus was purchased by Chicken Soup for the Soul.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Apps
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 111
  • Lead/follow: no public data

Portfolio highlights

  • QD-SOL — QD-SOL uses nanoparticles to produce green hydrogen in half the time.
  • Spicewell — Spicewell develops and creates food seasoning products that includes various kinds of micronutrients. It uses modern science to infuse healthy and organic additions to food meals. Spicewell is based in California, USA.
  • HempNFibers — Growing hemp. Making a bio fuel to start. Than also an insulation out of it as well. Will look at doing more as company grows. I also know a way to power a whole warehouse by just the plants it’s self but I need funding to get this started. I’m building the transportation side just so I can gain an income to try and get this started.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Angel Investors in LATAM investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 angel investors investing in LATAM Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists